Medtech mergers and acquisitions (M&A) and venture capital (VC) showed signs of life in 2024, contributing to an overall optimistic outlook for the sector this year despite lingering headwinds. Strategic investments are...more
Business investment in generative artificial intelligence (AI) is surging as companies seek to capitalize on its potential.
In 2024, generative AI business spending jumped to $13.8 billion, a sixfold increase from 2023,...more
Investment in artificial intelligence (AI) is rising fast. The International Data Corporation projects global spending on AI R&D will reach $632 billion by 2028, more than twice the expected total for 2024....more
11/4/2024
/ Artificial Intelligence ,
Data Privacy ,
Innovative Technology ,
Intellectual Property Protection ,
Investment Opportunities ,
Life Sciences ,
Machine Learning ,
Med Tech ,
Medical Devices ,
Open Source Software ,
Patents ,
Research and Development ,
Risk Management ,
Software ,
Technology ,
Technology Sector ,
Trade Secrets ,
USPTO
With remarkable speed, AI has evolved from an intriguing concept into a practical business tool that is drawing large investments and more regulatory oversight.
The launch of generative AI (GenAI) tools in late 2022 helped...more
7/25/2024
/ Artificial Intelligence ,
Corporate Counsel ,
EU ,
Innovative Technology ,
Investors ,
Legislative Agendas ,
Machine Learning ,
New Regulations ,
Patents ,
Proposed Legislation ,
Regulatory Agenda ,
Startups ,
Technology Sector ,
Young Lawyers
Generative AI (GenAI) surged to the forefront of corporate agendas and public policy debates last year, promising to boost productivity and innovation. What’s in store for AI in 2024?...more
1/17/2024
/ Artificial Intelligence ,
Authors ,
Authorship ,
Copyright ,
Copyright Infringement ,
Data Privacy ,
EU ,
General Data Protection Regulation (GDPR) ,
Innovative Technology ,
Inventors ,
Investors ,
IP License ,
Machine Learning ,
Patents ,
Pharmaceutical Industry ,
Popular ,
Privacy Concerns ,
Regulatory Oversight ,
Software ,
Technology Sector